Dow Up 0.82% Nasdaq Up 0.70%

Arrowhead Pharmaceuticals, Inc. (ARWR)

-NasdaqGS
5.88 Up 0.13(2.26%) May 25, 4:00PM EDT
Prev Close:5.75
Open:5.78
Bid:5.00 x 10000
Ask:5.87 x 2000
1y Target Est:9.69
Beta:2.50632
Earnings Date:Aug 2 - Aug 8 (Est.)
Day's Range:5.70 - 5.93
52wk Range:3.07 - 9.36
Volume:394,709
Avg Vol (3m):629,979
Market Cap:352.57M
P/E (ttm):N/A
EPS (ttm):-1.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARWR

Comparison

Symbol% ChgMkt Cap
ARWRUp 2.26%352.57M
PENCDown 6.35%8.50M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,352.04
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-16) :-1.40
Quarterly EPS Est (Jun-16) :-0.37
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-0.55

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Pharmaceuticals, Inc., a biopharmaceutical company, develops novel drugs to treat intractable diseases in the United States. The company utilizes its proprietary Dynamic Polyconjugate platform to develop targeted drugs based on the RNA i... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback